EUVIMEDEUVIMED entdecken
Open Access

Functional Diversity of Gram-Negative Permeability Barriers Reflected in Antibacterial Activities and Intracellular Accumulation of Antibiotics

Inga V Leus, Justyna Adamiak, Brinda Chandar, Vincent Bonifay, Shibin Zhao, Scott S Walker, Brian Squadroni, Carl J Balibar, Nihar Kinarivala, Lisa C Standke, Henning U Voss, Derek S Tan und 2 weitere

Antimicrobial Agents and Chemotherapy · 2023

DOI: 10.1128/aac.01377-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Inga V Leus und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry & Biochemistry, University of Oklahoma, Norman, Oklahoma, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Escherichia coli. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gram-negative bacteria are notoriously more resistant to antibiotics than Gram-positive bacteria, primarily due to the presence of the outer membrane and a plethora of active efflux pumps. However, the potency of antibiotics also varies dramatically between different Gram-negative pathogens, suggesting major mechanistic differences in how antibiotics penetrate permeability barriers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsEscherichia coliBiological TransportGram-Negative BacteriaPermeabilityMicrobial Sensitivity TestsPseudomonas aeruginosa

Stichwörter der Autor:innen

Gram-negative bacteriaantibiotic resistancedrug permeationmultidrug efflux

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Chemistry & Biochemistry, University of Oklahoma, Norman, Oklahoma, USA.
  • Chemical Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Merck & Co., Inc., Rahway, New Jersey, USA.
  • Pharmacology Program, Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Cornell MRI Facility, Cornell University, Ithaca, New York, USA.
  • Tri-Institutional Research Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

ORCID-Profile: Valentin V Rybenkov, Helen I Zgurskaya

Förderung

  • NIGMS NIH HHS
  • NCI NIH HHS
  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases

Zitieren

APA

Leus, I. V., Adamiak, J., Chandar, B., Bonifay, V., Zhao, S., Walker, S. S., Squadroni, B., Balibar, C. J., Kinarivala, N., Standke, L. C., Voss, H. U., Tan, D. S., Rybenkov, V. V., & Zgurskaya, H. I. (2023). Functional Diversity of Gram-Negative Permeability Barriers Reflected in Antibacterial Activities and Intracellular Accumulation of Antibiotics. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01377-22

Vancouver

Leus IV, Adamiak J, Chandar B, Bonifay V, Zhao S, Walker SS, et al. Functional Diversity of Gram-Negative Permeability Barriers Reflected in Antibacterial Activities and Intracellular Accumulation of Antibiotics. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.01377-22

BibTeX
@article{Leus2023,
  author = {Leus, Inga V and Adamiak, Justyna and Chandar, Brinda and Bonifay, Vincent and Zhao, Shibin and Walker, Scott S and Squadroni, Brian and Balibar, Carl J and Kinarivala, Nihar and Standke, Lisa C and Voss, Henning U and Tan, Derek S and Rybenkov, Valentin V and Zgurskaya, Helen I},
  title = {Functional Diversity of Gram-Negative Permeability Barriers Reflected in Antibacterial Activities and Intracellular Accumulation of Antibiotics},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  doi = {10.1128/aac.01377-22}
}
Kostenlos starten →